MD
MDT
Quarter ended Oct 24, 2025 · FY2026 Q2

Medtronic (MDT) Revenue — Quarter Ended Oct 24, 2025

Revenue increased in the current quarter, continuing the upward trajectory shown in recent periods. The performance reflected a year-over-year gain as well as sequential growth.

Key takeaway

Quarter ended Oct 24, 2025 · FY2026 Q2

Revenue increased in the current quarter, continuing the upward trajectory shown in recent periods. The performance reflected a year-over-year gain as well as sequential growth.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$9B

Revenue reported for this quarter.

Quarter-over-quarter

+4.5%

Change from the immediately preceding quarter.

Year-over-year

+6.6%

Change from the comparable year-ago quarter.

Trailing four quarters

$34.8B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jan 24, 2025$8.3B+2.5%
Apr 25, 2025$8.9B+3.9%
Jul 25, 2025$8.6B+8.4%
Oct 24, 2025$9B+6.6%

Revenue performance

Reported revenue was higher than both the immediately preceding quarter and the same quarter one year earlier.

Quarterly comparison

Compared with the prior quarter, revenue rose; compared with the same quarter last year, revenue also rose. The trailing twelve-month revenue stood at the reported level.

What to watch

The filing context discusses various risks and uncertainties, but does not attribute the reported revenue change to any specific cause.